Full text is available at the source.
Abstract
GLP-1 receptor agonist (GLP-1RA)-based insulin de-intensification was evaluated in adults with type 2 diabetes currently on basal-bolus insulin therapy.
- Comparison was made between GLP-1RA-based therapy and continued basal-bolus insulin therapy.
- Participants included adult outpatients with established basal-bolus insulin therapy.
- The analysis focused on the effects of insulin de-intensification strategies.
Simplified